Becton, Dickinson and Company
About Becton, Dickinson and Company
Becton, Dickinson and Company (BD) is a public company operating in the Medical Equipment Manufacturing industry with headquarters in Franklin Lakes, New Jersey, United States. Its website is www.bd.com and LinkedIn page is www.linkedin.com/company/bd1 with over 1.3 million followers. The company has conducted post-IPO equity and debt activities including a $2.75B Post-IPO Debt round and a $1.5B common stock plus $1.5B mandatory convertible preferred stock offering in 2020.
- 🔗 Becton, Dickinson and Company
- 🔗 BD Prices Offerings of $1.5 Billion of Common Stock and $1.5 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock :: Becton, Dickinson and Company (BDX)
- 🔗 Becton Dickinson - 2026 Company Profile & Financials - Tracxn
- 🔗 Should We Be Cautious About Becton, Dickinson and Company's (NYSE:BDX) ROE Of 5.1%?
- 🔗 Becton Dickinson Portfolio Investments, Becton Dickinson Funds, Becton Dickinson Exits
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed $396,868.13 Rule 144 placement with undisclosed investors
- Executed $3B public equity and preferred stock offering in 2020 for general corporate purposes
- Acquired Edwards Lifesciences Critical Care Product Group for $4.2B in 2024
Ask StreetZero about Becton, Dickinson and Company
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account